| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8229379 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 6 Pages |
Abstract
Our series suggests that patients with MS who receive GKRS may be at increased risk of rare and high-grade treatment-related toxicity. Given the time course of toxicity, treatment-related edema or demyelination represent potential mechanisms.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Dot M.D., Stephen B. M.D., Ph.D., J. Daniel Ph.D., Allan F. Ph.D., Kenneth E. Ph.D., Thomas L. M.D., James F. M.S., Kevin P. M.D., Michael T. Ph.D., Edward G. M.D., M.A., James J. M.D., Michael D. M.D.,